497 related articles for article (PubMed ID: 19858205)
41. CD39+ regulatory T cells attenuate allergic airway inflammation.
Li P; Gao Y; Cao J; Wang W; Chen Y; Zhang G; Robson SC; Wu Y; Yang J
Clin Exp Allergy; 2015 Jun; 45(6):1126-37. PubMed ID: 25728362
[TBL] [Abstract][Full Text] [Related]
42. Functional and phenotypic characteristics of CD4+CD25highFoxp3+ Treg clones obtained from peripheral blood of patients with cancer.
Strauss L; Bergmann C; Whiteside TL
Int J Cancer; 2007 Dec; 121(11):2473-83. PubMed ID: 17691114
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of CD4
McRae JL; Chia JS; Pommey SA; Dwyer KM
Nephrology (Carlton); 2017 Jul; 22(7):505-512. PubMed ID: 27517975
[TBL] [Abstract][Full Text] [Related]
44. Adenosine deaminase potentiates the generation of effector, memory, and regulatory CD4+ T cells.
Martinez-Navio JM; Casanova V; Pacheco R; Naval-Macabuhay I; Climent N; Garcia F; Gatell JM; Mallol J; Gallart T; Lluis C; Franco R
J Leukoc Biol; 2011 Jan; 89(1):127-36. PubMed ID: 20959412
[TBL] [Abstract][Full Text] [Related]
45. Low expression of CD39(+) /CD45RA(+) on regulatory T cells (Treg ) cells in type 1 diabetic children in contrast to high expression of CD101(+) /CD129(+) on Treg cells in children with coeliac disease.
Åkesson K; Tompa A; Rydén A; Faresjö M
Clin Exp Immunol; 2015 Apr; 180(1):70-82. PubMed ID: 25421756
[TBL] [Abstract][Full Text] [Related]
46. CD4+CD25+ regulatory T cells suppress contact hypersensitivity reactions through a CD39, adenosine-dependent mechanism.
Ring S; Oliver SJ; Cronstein BN; Enk AH; Mahnke K
J Allergy Clin Immunol; 2009 Jun; 123(6):1287-96.e2. PubMed ID: 19427686
[TBL] [Abstract][Full Text] [Related]
47. Mesenchymal stromal cells up-regulate CD39 and increase adenosine production to suppress activated T-lymphocytes.
Saldanha-Araujo F; Ferreira FI; Palma PV; Araujo AG; Queiroz RH; Covas DT; Zago MA; Panepucci RA
Stem Cell Res; 2011 Jul; 7(1):66-74. PubMed ID: 21546330
[TBL] [Abstract][Full Text] [Related]
48. Targeting adenosine and regulatory T cells in cancer immunotherapy.
Churov A; Zhulai G
Hum Immunol; 2021 Apr; 82(4):270-278. PubMed ID: 33610376
[TBL] [Abstract][Full Text] [Related]
49. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia.
Santner-Nanan B; Peek MJ; Khanam R; Richarts L; Zhu E; Fazekas de St Groth B; Nanan R
J Immunol; 2009 Dec; 183(11):7023-30. PubMed ID: 19915051
[TBL] [Abstract][Full Text] [Related]
50. Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis.
Grant CR; Liberal R; Holder BS; Cardone J; Ma Y; Robson SC; Mieli-Vergani G; Vergani D; Longhi MS
Hepatology; 2014 Mar; 59(3):1007-15. PubMed ID: 23787765
[TBL] [Abstract][Full Text] [Related]
51. CD73 expression on extracellular vesicles derived from CD4+ CD25+ Foxp3+ T cells contributes to their regulatory function.
Smyth LA; Ratnasothy K; Tsang JY; Boardman D; Warley A; Lechler R; Lombardi G
Eur J Immunol; 2013 Sep; 43(9):2430-40. PubMed ID: 23749427
[TBL] [Abstract][Full Text] [Related]
52. Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsiveness.
Hilchey SP; Kobie JJ; Cochran MR; Secor-Socha S; Wang JC; Hyrien O; Burack WR; Mosmann TR; Quataert SA; Bernstein SH
J Immunol; 2009 Nov; 183(10):6157-66. PubMed ID: 19864600
[TBL] [Abstract][Full Text] [Related]
53. STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+CD25- effector T cells.
Passerini L; Allan SE; Battaglia M; Di Nunzio S; Alstad AN; Levings MK; Roncarolo MG; Bacchetta R
Int Immunol; 2008 Mar; 20(3):421-31. PubMed ID: 18270368
[TBL] [Abstract][Full Text] [Related]
54. Surface expression of CD39 identifies an enriched Treg-cell subset in the rheumatic joint, which does not suppress IL-17A secretion.
Herrath J; Chemin K; Albrecht I; Catrina AI; Malmström V
Eur J Immunol; 2014 Oct; 44(10):2979-89. PubMed ID: 24990235
[TBL] [Abstract][Full Text] [Related]
55. Hydroxycarbamide modulates components involved in the regulation of adenosine levels in blood cells from sickle-cell anemia patients.
Silva-Pinto AC; Dias-Carlos C; Saldanha-Araujo F; Ferreira FI; Palma PV; Araujo AG; Queiroz RH; Elion J; Covas DT; Zago MA; Panepucci RA
Ann Hematol; 2014 Sep; 93(9):1457-65. PubMed ID: 24696091
[TBL] [Abstract][Full Text] [Related]
56. T regulatory and primed uncommitted CD4 T cells express CD73, which suppresses effector CD4 T cells by converting 5'-adenosine monophosphate to adenosine.
Kobie JJ; Shah PR; Yang L; Rebhahn JA; Fowell DJ; Mosmann TR
J Immunol; 2006 Nov; 177(10):6780-6. PubMed ID: 17082591
[TBL] [Abstract][Full Text] [Related]
57. Expression of CD39 on FoxP3+ T regulatory cells correlates with progression of HBV infection.
Tang Y; Jiang L; Zheng Y; Ni B; Wu Y
BMC Immunol; 2012 Apr; 13():17. PubMed ID: 22489829
[TBL] [Abstract][Full Text] [Related]
58. Selective expansion of memory CD4(+) T cells by mitogenic human CD28 generates inflammatory cytokines and regulatory T cells.
Singh M; Basu S; Camell C; Couturier J; Nudelman RJ; Medina MA; Rodgers JR; Lewis DE
Eur J Immunol; 2008 Jun; 38(6):1522-32. PubMed ID: 18446791
[TBL] [Abstract][Full Text] [Related]
59. Foxp3 regulates human natural CD4+CD25+ regulatory T-cell-mediated suppression of xenogeneic response.
Sun L; Yi S; O'Connell PJ
Xenotransplantation; 2010; 17(2):121-30. PubMed ID: 20522244
[TBL] [Abstract][Full Text] [Related]
60. CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease.
Chen X; Zhou B; Li M; Deng Q; Wu X; Le X; Wu C; Larmonier N; Zhang W; Zhang H; Wang H; Katsanis E
Clin Immunol; 2007 Apr; 123(1):50-9. PubMed ID: 17234458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
